Testing the applicability and performance of Auto ML for potential applications in diagnostic neuroradiology.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 08 2022
11 08 2022
Historique:
received:
07
05
2022
accepted:
03
08
2022
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
To investigate the applicability and performance of automated machine learning (AutoML) for potential applications in diagnostic neuroradiology. In the medical sector, there is a rapidly growing demand for machine learning methods, but only a limited number of corresponding experts. The comparatively simple handling of AutoML should enable even non-experts to develop adequate machine learning models with manageable effort. We aim to investigate the feasibility as well as the advantages and disadvantages of developing AutoML models compared to developing conventional machine learning models. We discuss the results in relation to a concrete example of a medical prediction application. In this retrospective IRB-approved study, a cohort of 107 patients who underwent gross total meningioma resection and a second cohort of 31 patients who underwent subtotal resection were included. Image segmentation of the contrast enhancing parts of the tumor was performed semi-automatically using the open-source software platform 3D Slicer. A total of 107 radiomic features were extracted by hand-delineated regions of interest from the pre-treatment MRI images of each patient. Within the AutoML approach, 20 different machine learning algorithms were trained and tested simultaneously. For comparison, a neural network and different conventional machine learning algorithms were trained and tested. With respect to the exemplary medical prediction application used in this study to evaluate the performance of Auto ML, namely the pre-treatment prediction of the achievable resection status of meningioma, AutoML achieved remarkable performance nearly equivalent to that of a feed-forward neural network with a single hidden layer. However, in the clinical case study considered here, logistic regression outperformed the AutoML algorithm. Using independent test data, we observed the following classification results (AutoML/neural network/logistic regression): mean area under the curve = 0.849/0.879/0.900, mean accuracy = 0.821/0.839/0.881, mean kappa = 0.465/0.491/0.644, mean sensitivity = 0.578/0.577/0.692 and mean specificity = 0.891/0.914/0.936. The results obtained with AutoML are therefore very promising. However, the AutoML models in our study did not yet show the corresponding performance of the best models obtained with conventional machine learning methods. While AutoML may facilitate and simplify the task of training and testing machine learning algorithms as applied in the field of neuroradiology and medical imaging, a considerable amount of expert knowledge may still be needed to develop models with the highest possible discriminatory power for diagnostic neuroradiology.
Identifiants
pubmed: 35953588
doi: 10.1038/s41598-022-18028-8
pii: 10.1038/s41598-022-18028-8
pmc: PMC9366823
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13648Informations de copyright
© 2022. The Author(s).
Références
Sci Rep. 2019 Oct 9;9(1):14481
pubmed: 31597942
Artif Intell Med. 2020 Apr;104:101822
pubmed: 32499001
Front Neurol. 2021 Nov 29;12:735142
pubmed: 34912282
J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39
pubmed: 13406590
Sci Rep. 2022 Feb 14;12(1):2398
pubmed: 35165304
J Med Internet Res. 2021 Feb 26;23(2):e23458
pubmed: 33539308
Eur Radiol. 2019 Jan;29(1):124-132
pubmed: 29943184
Eur J Radiol. 2019 Jul;116:128-134
pubmed: 31153553
Sci Rep. 2021 Jul 23;11(1):15107
pubmed: 34302024
NPJ Digit Med. 2020 Sep 24;3:126
pubmed: 33043150
J Comput Assist Tomogr. 2021 Jul-Aug 01;45(4):606-613
pubmed: 34270479
Neuroinformatics. 2021 Jul;19(3):393-402
pubmed: 32974873
J Clin Med. 2020 Sep 18;9(9):
pubmed: 32962113
J Neurooncol. 2017 Jul;133(3):641-651
pubmed: 28527009